Ambergen
Watertown, US · Founded 2022 · Delaware corporation
Biotech
Founders & leadership
ME
Michael EasterlingDirector
KR
Kenneth RothschildExecutive Officer, Director
JG
John GillespieExecutive Officer, Director
PF
Peter FinnExecutive Officer
BR
Brian RothschildDirector
Reported raises · per SEC filings
Form D private placements▶$5MraisedApr 2022 · 1 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Michael EasterlingDirector
- Kenneth RothschildExecutive Officer, Director
- John GillespieExecutive Officer, Director
- Peter FinnExecutive Officer
- Brian RothschildDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.